Modulation of the cholesterol or Wnt signaling pathways overcomes TP53 deficiency-associated resistance to CAR T-cell therapy in AML J. Mueller, R. Schimmer,F. Schneiter, J. Fullin, N. Klemm,V. Lysenko, C. Pellegrino,R. Myburgh, L. Volta, C. Koch,A. P. A. Theocharides, K. J. Kurppa, B. L. Ebert, T. Schroeder,M. G. Manz,S. BoettcherSWISS MEDICAL WEEKLY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
